Literature DB >> 29186695

Amyloid Accumulation Drives Proteome-wide Alterations in Mouse Models of Alzheimer's Disease-like Pathology.

Jeffrey N Savas1, Yi-Zhi Wang2, Laura A DeNardo3, Salvador Martinez-Bartolome4, Daniel B McClatchy4, Timothy J Hark2, Natalie F Shanks5, Kira A Cozzolino2, Mathieu Lavallée-Adam6, Samuel N Smukowski2, Sung Kyu Park4, Jeffery W Kelly4, Edward H Koo7, Terunaga Nakagawa5, Eliezer Masliah7, Anirvan Ghosh3, John R Yates8.   

Abstract

Amyloid beta (Aβ) peptides impair multiple cellular pathways and play a causative role in Alzheimer's disease (AD) pathology, but how the brain proteome is remodeled by this process is unknown. To identify protein networks associated with AD-like pathology, we performed global quantitative proteomic analysis in three mouse models at young and old ages. Our analysis revealed a robust increase in Apolipoprotein E (ApoE) levels in nearly all brain regions with increased Aβ levels. Taken together with prior findings on ApoE driving Aβ accumulation, this analysis points to a pathological dysregulation of the ApoE-Aβ axis. We also found dysregulation of protein networks involved in excitatory synaptic transmission. Analysis of the AMPA receptor (AMPAR) complex revealed specific loss of TARPγ-2, a key AMPAR-trafficking protein. Expression of TARPγ-2 in hAPP transgenic mice restored AMPA currents. This proteomic database represents a resource for the identification of protein alterations responsible for AD.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AD; AMPAR; ApoE; WGCNA; amyloid beta; mass spectrometry; proteomics; proteostasis; synapses

Mesh:

Substances:

Year:  2017        PMID: 29186695      PMCID: PMC5726791          DOI: 10.1016/j.celrep.2017.11.009

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  62 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.

Authors:  V B Gupta; S M Laws; V L Villemagne; D Ames; A I Bush; K A Ellis; J K Lui; C Masters; C C Rowe; C Szoeke; K Taddei; R N Martins
Journal:  Neurology       Date:  2011-03-22       Impact factor: 9.910

3.  Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles.

Authors:  H Lassmann; R Weiler; P Fischer; C Bancher; K Jellinger; E Floor; W Danielczyk; F Seitelberger; H Winkler
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

4.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

5.  A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.

Authors:  Nicholas T Seyfried; Eric B Dammer; Vivek Swarup; Divya Nandakumar; Duc M Duong; Luming Yin; Qiudong Deng; Tram Nguyen; Chadwick M Hales; Thomas Wingo; Jonathan Glass; Marla Gearing; Madhav Thambisetty; Juan C Troncoso; Daniel H Geschwind; James J Lah; Allan I Levey
Journal:  Cell Syst       Date:  2016-12-15       Impact factor: 10.304

6.  Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3.

Authors:  Niels R Reinders; Yvonne Pao; Maria C Renner; Carla M da Silva-Matos; Tessa R Lodder; Roberto Malinow; Helmut W Kessels
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-05       Impact factor: 11.205

7.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

8.  Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology.

Authors:  Yong Kim; Jee Young Sung; Ilaria Ceglia; Ko-Woon Lee; Jung-Hyuck Ahn; Jonathan M Halford; Amie M Kim; Seung P Kwak; Jong Bae Park; Sung Ho Ryu; Annette Schenck; Barbara Bardoni; John D Scott; Angus C Nairn; Paul Greengard
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

9.  Ultrastructural localization of Alzheimer amyloid beta/A4 protein precursor in the cytoplasm of neurons and senile plaque-associated astrocytes.

Authors:  H Yamaguchi; T Yamazaki; K Ishiguro; M Shoji; Y Nakazato; S Hirai
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 10.  The amyloid hypothesis of Alzheimer's disease at 25 years.

Authors:  Dennis J Selkoe; John Hardy
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137

View more
  24 in total

1.  Proteomics INTegrator (PINT): An Online Tool To Store, Query, and Visualize Large Proteomics Experiment Results.

Authors:  Salvador Martínez-Bartolomé; Tom Casimir Bamberger; Mathieu Lavallée-Adam; Daniel B McClatchy; John R Yates
Journal:  J Proteome Res       Date:  2019-07-01       Impact factor: 4.466

2.  Widespread Dysregulation of Long Noncoding Genes Associated With Fatty Acid Metabolism, Cell Division, and Immune Response Gene Networks in Xenobiotic-exposed Rat Liver.

Authors:  Kritika Karri; David J Waxman
Journal:  Toxicol Sci       Date:  2020-04-01       Impact factor: 4.849

3.  Proteomic Atlas of the Human Brain in Alzheimer's Disease.

Authors:  Justin McKetney; Rosalyn M Runde; Alexander S Hebert; Shahriar Salamat; Subhojit Roy; Joshua J Coon
Journal:  J Proteome Res       Date:  2019-02-20       Impact factor: 4.466

4.  Graphene quantum dots rescue protein dysregulation of pancreatic β-cells exposed to human islet amyloid polypeptide.

Authors:  Ava Faridi; Yunxiang Sun; Monika Mortimer; Ritchlynn R Aranha; Aparna Nandakumar; Yuhuan Li; Ibrahim Javed; Aleksandr Kakinen; Qingqing Fan; Anthony W Purcell; Thomas P Davis; Feng Ding; Pouya Faridi; Pu Chun Ke
Journal:  Nano Res       Date:  2019-09-26       Impact factor: 8.897

5.  Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease.

Authors:  Jiansong Fang; Pengyue Zhang; Yadi Zhou; Chien-Wei Chiang; Juan Tan; Yuan Hou; Shaun Stauffer; Lang Li; Andrew A Pieper; Jeffrey Cummings; Feixiong Cheng
Journal:  Nat Aging       Date:  2021-12-06

6.  Isobaric Labeling Strategy Utilizing 4-Plex N,N-Dimethyl Leucine (DiLeu) Tags Reveals Proteomic Changes Induced by Chemotherapy in Cerebrospinal Fluid of Children with B-Cell Acute Lymphoblastic Leukemia.

Authors:  Qinying Yu; Xiaofang Zhong; Bingming Chen; Yu Feng; Min Ma; Carol A Diamond; Julie S Voeller; Miriam Kim; Kenneth B DeSantes; Christian M Capitini; Neha J Patel; Margo L Hoover-Regan; Michael J Burke; Kimberly Janko; Diane M Puccetti; Chrysanthy Ikonomidou; Lingjun Li
Journal:  J Proteome Res       Date:  2020-05-27       Impact factor: 4.466

Review 7.  Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing.

Authors:  Jiansong Fang; Andrew A Pieper; Ruth Nussinov; Garam Lee; Lynn Bekris; James B Leverenz; Jeffrey Cummings; Feixiong Cheng
Journal:  Med Res Rev       Date:  2020-07-13       Impact factor: 12.944

8.  Pulse-Chase Proteomics of the App Knockin Mouse Models of Alzheimer's Disease Reveals that Synaptic Dysfunction Originates in Presynaptic Terminals.

Authors:  Timothy J Hark; Nalini R Rao; Charlotte Castillon; Tamara Basta; Samuel Smukowski; Huan Bao; Arun Upadhyay; Ewa Bomba-Warczak; Toshihiro Nomura; Eileen T O'Toole; Garry P Morgan; Laith Ali; Takashi Saito; Christelle Guillermier; Takaomi C Saido; Matthew L Steinhauser; Michael H B Stowell; Edwin R Chapman; Anis Contractor; Jeffrey N Savas
Journal:  Cell Syst       Date:  2020-12-15       Impact factor: 10.304

Review 9.  Using stable isotope labeling to advance our understanding of Alzheimer's disease etiology and pathology.

Authors:  Timothy J Hark; Jeffrey N Savas
Journal:  J Neurochem       Date:  2021-02-02       Impact factor: 5.546

10.  Following spatial Aβ aggregation dynamics in evolving Alzheimer's disease pathology by imaging stable isotope labeling kinetics.

Authors:  Wojciech Michno; Katie M Stringer; Thomas Enzlein; Melissa K Passarelli; Stephane Escrig; Karina Vitanova; Jack Wood; Kaj Blennow; Henrik Zetterberg; Anders Meibom; Carsten Hopf; Frances A Edwards; Jörg Hanrieder
Journal:  Sci Adv       Date:  2021-06-16       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.